LA FRANCE REFUSE UNE TECHNOLOGIE QUE LES ÉTATS-UNIS S’ARRACHENT

He left the stars to enter our cells. On Friday, June 12th at 12:00 PM, live, I'll be interviewing Sacha Loiseau, founder and CEO of Mauna Kea Technologies. A graduate of École Polytechnique and a PhD in astrophysics, he left the observation of the infinitely large to invent Cellvizio, the world's smallest microscope. Its use is very practical. When a doctor discovers a cyst on the pancreas, they don't know if it's dangerous or benign. In the absence of certainty, surgery is often performed unnecessarily. Cellvizio slides a tiny probe into contact with the cells and films them live on the screen. During the examination, the doctor can see if the cyst is likely to become cancerous. Fewer unnecessary surgeries, immediate diagnosis. In the United States, the technology is taking off. It already accounts for 77% of Mauna Kea's sales there, an 82% increase in just one quarter. The European Society of Endoscopy recommends it. And in France? Reimbursement for this application is still only a possibility. It's a French invention that American doctors use daily, and that French patients are still waiting for. Live, we're discussing: → How to avoid pancreatic surgery thanks to a microscope → Why Americans adopted it before France → How an astrophysicist ended up reinventing cancer diagnosis